Using blood tests to analyze tumor DNA in breast and digestive cancers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of circulating tumor DNA (ctDNA) obtained from blood samples to improve the management of patients with breast, digestive, and gynecologic cancers. By employing advanced molecular biology techniques like Next Generation Sequencing (NGS), the study aims to assess the diagnostic, prognostic, and predictive capabilities of ctDNA in response to oncological treatments. Additionally, the study explores the potential of exosomes as future biomarkers in cancer management. The research focuses on patients requiring chemotherapy or immunotherapy, providing a non-invasive method to monitor tumor characteristics.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Digestive or gynecological / breast cancer proven or suspected, requiring oncological treatment (chemotherapy or immunotherapy)
* Major patient
* Patients benefiting from a Social Security scheme or benefiting through the intermediary of a third party
* Information note and collection of non-opposition after clear and fair information about the study

Exclusion Criteria:

* Linguistic or psychological refusal or inability to understand and / or sign the information and no-objection note
* History of a cancer other than that allowing inclusion in the 5 years preceding inclusion

Where it's running

• CHU POitiers
  Poitiers, France Recruiting

Study contacts

• Study coordinator: Camille EVRARD, PHD
• Email: camille.evrard@chu-poitiers.fr
• Phone: +33549444279

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Creating a database for cancer research and treatment

  This study is creating a detailed database to help researchers understand different types of cancer better and improve treatments for patients.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier · NCT03449264

• Personalized supervised exercise program for adults with breast or gynecologic cancer

  A small pilot study will test a supervised, personalized exercise program to see if it is safe, feasible, and acceptable for adults with a history of breast or gynecologic cancer.

  Recruiting University of Iowa · Iowa City, Iowa · NCT07765927

• High-precision detection of leftover cancer using a liquid-biopsy platform (SHERLOCK)

  This project will test whether sensitive blood and other fluid tests for circulating tumor DNA can find leftover cancer (minimal residual disease) in adults treated with curative intent for breast, lung, melanoma, gynecologic, or genitourinary cancers.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07524114

• Riluzole to prevent thinking and memory problems during chemotherapy

  This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07447050

• Web app for reporting side effects during radiation therapy

  This project will try a web app that lets people receiving radiation for breast, gynecologic, or urologic cancers report symptoms and quality of life so clinicians can spot problems earlier.

  Recruiting Institute of Oncology Ljubljana · Ljubljana · NCT07416630

• 7-day Via Shalva integrative retreat for breast and gynecologic cancer survivors

  This pilot will try a 7-day integrative retreat called Via Shalva for breast and gynecologic cancer survivors to see if the program is feasible and whether participants show changes in symptoms, wearable physiological data, and biological markers versus matched controls.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT07398079

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.